MJ advocacy group celebrates win over DEA ‘misinformation’

Americans for Safe Access claimed partial victory over the U.S. Drug Enforcement Administration when it announced the federal agency had removed “factually inaccurate information” and “damaging misinformation” regarding cannabis from its website.

The DEA removed information from its site that included “claims that cannabis was a gateway drug, caused irreversible cognitive decline in adults, and contributed to psychosis and lung cancer,” according to a news release Monday by ASA, a nonprofit dedicated to promoting medical cannabis.

The DEA made the change after ASA filed a legal challenge over the agency’s website last year under the Information Quality Act.

Spring 2017 MJBizCon“The DEA’s removal of these popular myths about cannabis from their website could mean the end of the Washington gridlock” regarding scientific information about marijuana, Steph Sherer, ASA’s executive director, said in the release.

However, Americans for Safe Access claims the DEA is continuing to spread misinformation about marijuana, though the group did not offer specifics.

Correcting misinformation is paramount, the ASA argued, especially given that newly confirmed Attorney General Jeff Sessions has said he believes cannabis is a gateway drug and can cause long-term psychological damage to consumers.

“These beliefs are verifiably false,” ASA wrote in a letter delivered to the DEA on Monday. “Allowing Mr. Sessions to make law enforcement decisions based on biased, out-of-date information does a tremendous disservice to ASA’s members and the American people at large.”

Daily News | Briefs | Legal & Regulatory News for Marijuana Businesses | National Medical Cannabis Business & Marijuana Legal News

 3 Comments

  1. Cindy February 15, 2017
  2. Paul Sorensen February 15, 2017
  3. Stan Cox February 15, 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.